In the intricate world of pharmaceutical manufacturing, the selection of high-quality intermediates is paramount to the success of drug development and production. Among these crucial compounds, Cis-2-(Bromomethyl)-2-(2,4-Dichlorophenyl)-1,3-Dioxolane-4-Ylmethyl Benzoate, identified by its CAS number 61397-56-6, stands out as a vital building block. This article delves into the significance of this intermediate and guides procurement managers and R&D scientists on how to effectively source it, particularly from reputable China manufacturers.

The Critical Role of CAS 61397-56-6 in Antifungal Synthesis

Cis-2-(Bromomethyl)-2-(2,4-Dichlorophenyl)-1,3-Dioxolane-4-Ylmethyl Benzoate is a key intermediate primarily utilized in the synthesis of potent antifungal agents. Its chemical structure, featuring a bromomethyl group and a 2,4-dichlorophenyl moiety, provides the necessary reactivity and specificity for creating complex molecules like Ketoconazole and Itraconazole. These drugs are cornerstones in treating a wide spectrum of fungal infections, underscoring the importance of a consistent and high-purity supply of this intermediate. For any pharmaceutical company involved in producing these life-saving antifungals, understanding the properties and sourcing of CAS 61397-56-6 is non-negotiable.

Why Source from China? Advantages for Buyers

When seeking to buy Cis-2-(Bromomethyl)-2-(2,4-Dichlorophenyl)-1,3-Dioxolane-4-Ylmethyl Benzoate, manufacturers often turn to China due to its robust chemical manufacturing sector. The advantages of sourcing from China include competitive pricing, large-scale production capabilities, and a well-established supply chain for pharmaceutical intermediates. By partnering with a reputable China manufacturer, businesses can secure a stable supply of high-quality product at a price that significantly impacts their cost of goods sold. This strategic sourcing allows companies to focus on their core competencies, such as drug formulation and marketing, while ensuring a reliable supply of essential raw materials.

Key Considerations When Purchasing CAS 61397-56-6

Procurement managers and research scientists must prioritize several factors when purchasing this intermediate. Firstly, purity is critical. A minimum purity of 98% is generally required for pharmaceutical applications to ensure the efficacy and safety of the final drug product. Secondly, the reliability of the supplier is paramount. Look for manufacturers with a proven track record, certifications, and positive customer testimonials. Thirdly, understanding the manufacturer's production capacity and lead times is essential for production planning. When you purchase this intermediate, ensure it meets all regulatory and quality standards for your intended market. Obtaining a free sample from potential suppliers can be a valuable step in the vendor qualification process.

The Future of Antifungal Drug Production

As fungal infections continue to pose a global health challenge, the demand for effective antifungal agents remains high. Cis-2-(Bromomethyl)-2-(2,4-Dichlorophenyl)-1,3-Dioxolane-4-Ylmethyl Benzoate will continue to play a pivotal role in meeting this demand. Pharmaceutical companies looking to expand their antifungal portfolios or ensure a consistent supply for existing products should establish strong relationships with trusted pharmaceutical intermediate manufacturers. Investing in a reliable supplier for CAS 61397-56-6 is an investment in the future of antifungal drug production and patient health. If you are seeking to purchase this vital intermediate, explore options with experienced China suppliers who offer competitive pricing and commitment to quality.